Explaining rapid growth in Canadian biotechnology firms - ARCHIVED

Articles and reports: 88-003-X20000035770


Given the high cost of R&D, adopting the correct strategies and mix of products is required for success for Canadian biotechnology firms. A recent survey examined the rapid growth of 30 companies. Fast-growing enterprises adopted a strategy of patenting their products, avoiding major production delays, targeting export markets, accessing venture capital, conducting key alliances, and planning the IPO.

Issue Number: 2000003
Author(s): Rose, Antoine
FormatRelease dateMore information
PDFOctober 6, 2000